COMPANY

Spectros Medical Devices

FDA-cleared device company Past trials only

Keywords: medical device medical devices Prostate Cancer Ischemia Colon Ischemia Aortic Aneurysm Necrotizing Enterocolitis Breast Lesions Breast Cyst Early-Stage Breast Cancer Breast Benign Growth

Location: Houston, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

2011-12 Trial start —: Imaging of Residual Tumor During Prostatectomy source ↗
2011-03 Trial start —: Monitoring Necrotizing Enterocolitis in Premature Infants source ↗
2009-04 Trial start —: Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery source ↗
2008-04 Trial start —: Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning source ↗
2007-06 Trial start Phase 3: Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair source ↗

Clinical trials (lead sponsor) 5

Record	Title	Phase	Status	Start	Primary completion
NCT01173146	Imaging of Residual Tumor During Prostatectomy	Not listed	Withdrawn	2011-12	2015-06 (actual)
NCT01173133	Skin Flap Visible Light Spectroscopy (VLS) Oximetry for Monitoring Free-Flap Ischemia During Breast Reconstruction and Recovery	Not listed	Unknown status (ClinicalTrials.gov)	2009-04	2010-12 (estimated)
NCT00671203	Prevention of Colon Ischemia During Aortic Aneurysm (AAA) Repair	Phase 3	Completed	2007-06	2010-09 (actual)
NCT01287559	Monitoring Necrotizing Enterocolitis in Premature Infants	Not listed	Unknown status (ClinicalTrials.gov)	2011-03	2011-12 (estimated)
NCT00671385	Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning	Not listed	Unknown status (ClinicalTrials.gov)	2008-04	2009-04 (estimated)